IGA×BSA:评估儿童特应性皮炎严重程度的实用替代工具
本研究在195例5-17岁儿童特应性皮炎患者中,评估研究者整体评估与体表面积乘积(IGA×BSA)作为简易严重度指标的效能。结果显示IGA×BSA与EASI相关性(r=0.924)优于单独IGA(r=0.757),并提出了轻度0-30、中度30.1-130、重度130.1-400的严重度分层(κ=0.760)。
要点
- IGA×BSA与EASI相关性高(r=0.924),优于单独IGA(r=0.757)。
- 建议严重度分层:0-30轻度,30.1-130中度,130.1-400重度。
- IGA×BSA使用vIGA,适用于儿童轻至重度特应性皮炎。
核心结论
- IGA×BSA(使用vIGA)与EASI在儿童轻至重度特应性皮炎中相关性良好,是一种简易的严重度测量工具。
研究设计与样本
- 收集195例5-17岁儿童及其照护者的患者报告和客观疾病严重度指标,vIGA范围1(几乎清除)至4(重度)。
- 采用Spearman相关系数和图表分析数据,并基于EASI的锚定方法提出严重度分层。
主要发现
- IGA×BSA与EASI的相关系数r=0.924,高于单独IGA的r=0.757(P < .001)。
- Bland-Altman图显示IGA×BSA与EASI之间高度且一致的一致性。
- 提出的IGA×BSA严重度分层为0-30轻度、30.1-130中度、130.1-400重度(κ = 0.760)。
关键数值与推荐
- IGA×BSA与EASI相关系数r=0.924,单独IGA r=0.757(P < .001)。
- 严重度分层:0-30轻度;30.1-130中度;130.1-400重度(κ = 0.760)。
临床怎么用
- 临床可采用IGA×BSA快速评估儿童特应性皮炎严重度,减少EASI耗时。
- 依据分层标准(0-30轻度,30.1-130中度,130.1-400重度)进行严重度判断。
局限性
- 患者队列主要来自美国中西部。
- 未来需验证跨IGA量表的可靠性和对变化的反应性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurately documenting pediatric atopic dermatitis (AD) severity is important, but research tools, such as Eczema Area and Severity Index (EASI), are too time consuming for clinical settings. Product of the Physician Global Assessment and affected percentage of body surface area (PGA×BSA) is a new, rapid measure of psoriasis severity. OBJECTIVE: To evaluate an Investigator Global Assessment and body surface area product (IGA×BSA) as an easy-to-use severity measure for pediatric AD. METHODS: Patient-reported and objective disease severity measures were collected from 195 caretaker/child dyads (child age range, 5-17 years) with almost clear (Validated Investigator Global Assessment for AD [vIGA] of 1) to severe (vIGA of 4) AD. Data were assessed with Spearman coefficients and plots. Severity strata were proposed by using an anchoring approach based on the EASI. RESULTS: IGA×BSA correlates better with the EASI than IGA alone (r = 0.924 vs r = 0.757, P < .001). Bland-Altman plot indicates high and consistent agreement between IGA×BSA and the EASI. Suggested severity strata for IGA×BSA are 0-30, mild; 30.1-130, moderate; and 130.1-400, severe (κ = 0.760). LIMITATIONS: The patient cohort was predominantly from the midwestern United States. CONCLUSIONS: IGA×BSA (using the vIGA) is a simple measure that correlates well with the EASI in patients with mild to severe pediatric AD. Future work is needed to affirm reliability across IGA scales and responsiveness to change.
引用
- Suh TP, Ramachandran D, Patel V, et al. Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children. J Am Acad Dermatol. 2020. PMID: 31972257. doi:10.1016/j.jaad.2020.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。